Pedro Horna

Dr. Pedro Horna is a Hematopathologist at Mayo Clinic in Rochester, Minnesota. His work focuses on flow cytometry applications in diagnosing T-cell and B-cell neoplasms, with particular expertise in minimal residual disease (MRD) detection and immunophenotyping.

• 2011 Hematopathology Fellow - Medical College of Wisconsin
• 2010 Anatomic & Clinical Pathology Resident - University of Texas Southwestern
• 2006 Postdoc in Tumor Immunology - H. Lee Moffitt Cancer Center

His research interests include:

• Molecular mechanisms of T-cell tolerance in cancer
• Development of flow cytometry assays for lymphoma/myeloma
• Clonal evolution in cutaneous lymphomas
• TRBC1/TRBC2 expression patterns in T-cell malignancies
• Clinical validation of hematologic diagnostics

Recent publications highlight his work on TRBC1-based assays for T-cell clonality, machine learning applications in cytometry, and AML/MDS diagnostic protocols.

Scientific recognition includes:

• 2022 Hematopathology Certification - American Board of Pathology
• 2021 Top Cited Article - Cytometry Part B
• 2020 Best Original Paper - Cytometry

Professional memberships span the American Society of Hematology, International Society for Cutaneous Lymphomas, and International Clinical Cytometry Society, among others.